Metallodrugs in medicinal inorganic chemistry

Chemical Reviews

Volumn 114, Issue 8, 2014, Pages 4540-4563

  Mjos, Katja Dralle ^a   Orvig, Chris ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; COMPLEXATION; COORDINATION REACTIONS; EXPERIMENTS; INORGANIC COMPOUNDS; NITRIC OXIDE; PLATINUM COMPOUNDS; VIRUSES;

ANTICANCER DRUG; CARDIO-VASCULAR DISEASE; CLINICAL TRIAL; COORDINATION COMPLEX; HERPES SIMPLEX; INORGANIC CHEMISTRY; MEDICAL TREATMENT; METAL-LIGAND COMPLEXES;

DISEASES;

METAL;

ANIMAL; CHEMISTRY; DRUG DESIGN; HUMAN; INORGANIC CHEMISTRY; MEDICINAL CHEMISTRY; PROCEDURES;

ANIMALS; CHEMISTRY, INORGANIC; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; HUMANS; METALS;

EID: 84899542130     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/cr400460s     Document Type: Review

References (284)

1. Sigel, A.; Sigel, H.; Sigel, R. K. Metal Ions in Biological Systems & Metal Ions in Life Sciences; various books and numerous chapters.
2. Thompson, K. H. In Encyclopedia of Inorganic Chemistry; King, R. B., Ed.; John Wiley & Sons Ltd.: Chichester, UK, 2011; Chapter 1, pp 1-10.
3. Magner, L. N. A History of Medicine, 2 nd ed.; Taylor & Francis Group, LLC: Boca Raton, FL, 2005.
4. Orvig, C.; Abrams, M. J. Chem. Rev. 1999, 99, 2201
5. Thompson, K. H.; Orvig, C. In Concepts and Models in Bioinorganic Chemistry; Kraatz, H.-B.; Metzler-Nolte, N., Eds.; Wiley-VCH: Weinheim, Germany, 2006; Chapter 2, pp 25-46.
6. Thompson, K. H.; Orvig, C. Science 2003, 300, 936
7. Canadian Institute for Health Information. Executive Summary: Medical Imaging in Canada 2012; CIHI Publication: Ottawa, 2013.
8. Ehrlich, P.; Bertheim, A. Ber. Dtsch. Chem. Ges. 1912, 45, 756
9. Lloyd, N. C.; Morgan, H. W.; Nicholson, B. K.; Ronimus, R. S. Angew. Chem., Int. Ed. 2005, 44, 941
10. Chast, F. In The Practice of Medicinal Chemistry, 3 rd ed.; Wermuth, C. G.; Kubinyi, H., Eds.; Academic Press, Elsevier Ltd.: London, UK, 2008, Chapter 1, pp 3-62.
11. Rosenberg, B.; VanCamp, L.; Krigas, T. Nature 1965, 205, 698
12. Rosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Nature 1969, 222, 385
13. Alderden, R. A.; Hall, M. D.; Hambley, T. W. J. Chem. Educ. 2006, 83, 728
14. Hambley, T. W. Science 2007, 318, 1392
15. Meade, T. Chem. Rev., in this edition.
16. Kraatz, H.-B.; Metzler-Nolte, N., Eds. Concepts and Models in Bioinorganic Chemistry; Wiley-VCH: Weinheim, Germany, 2006.
17. Jones, C. J.; Thornback, J. R. Medicinal Applications of Coordination Chemistry; Royal Society of Chemistry: Cambridge, UK, 2007.
18. Alessio, E., Ed. Bioinorganic Medicinal Chemistry, 1 st ed.; Wiley-VCH: Weinheim, Germany, 2011.
19. Dabrowiak, J. C. Metals in Medicine; John Wiley & Sons Ltd.: Chichester, UK, 2009.
20. Farrell, N. P., Ed. Uses of Inorganic Chemistry in Medicine, 1 st ed.; Royal Society of Chemistry: Cambridge, UK, 1999.
21. Gielen, M.; Tiekink, E. R. T., Eds. Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine, 1 st ed.; John Wiley & Sons Ltd.: Chichester, UK, 2005.
22. Gaynor, D.; Griffith, D. M. Dalton Trans. 2012, 41, 13239
23. Casini, A. J. Inorg. Biochem. 2012, 109, 97
24. Guo, Z.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, 38, 1512
25. Special Edition: Metal Anticancer Compounds. Dalton Trans. 2009, 10629-10936.
26. Komeda, S.; Casini, A. Curr. Top. Med. Chem. 2012, 12, 219
27. Farrell, N. P. Curr. Top. Med. Chem. 2011, 11, 2623
28. Ott, I. Coord. Chem. Rev. 2009, 253, 1670
29. Special Edition: Radiopharmaceuticals for Imaging and Therapy. Dalton Trans. 2011, 40, 6057-6300.
30. Anderson, C. J.; Welch, M. J. Chem. Rev. 1999, 99, 2219
31. Bourassa, M. W.; Miller, L. M. Metallomics 2012, 4, 721
32. Banerjee, S.; Raghavan, M.; Pillai, M. R. A.; Ramamoorthy, N. Semin. Nucl. Med. 2001, 31, 260
33. Cardinal Health. FDA-Approved Radiopharmaceuticals; Rev. 8 No. 6.5.13; http://www.cardinal.com/mps/wcm/connect/1bcdfc80447f1763b29ab77fc4070dc5/ 7COMPLI9958-FDA-approved-list-082412-v3.pdf?MOD=AJPERES (last accessed October 11, 2013).
34. Nunn, A. D. Invest. Radiol. 2006, 41, 206
35. Josephson, L.; Rudin, M. J. Nucl. Med. 2013, 54, 329
36. Batholomä, M. D.; Louie, A. S.; Valliant, J. F.; Zubieta, J. Chem. Rev. 2010, 110, 2903
37. Banerjee, S. R.; Maresca, K. P.; Francesconi, L.; Valliant, J.; Babich, J. W.; Zubieta, J. Nucl. Med. Biol. 2005, 32, 1
38. Liu, S.; Edwards, D. S. Chem. Rev. 1999, 99, 2235
39. Rösch, F. Appl. Radiat. Isot. 2013, 76, 24
40. Breeman, W. A. P.; Verbruggen, A. M. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 978
41. Eckert & Ziegler GmbH, Berlin; http://www.ezag.com (last accessed July 22, 2013).
42. OctreoPharm Sciences GmbH, Berlin; http://www.octreopharmsciences.com (last accessed July 22, 2013).
43. Rösch, F.; Baum, R. P. Dalton Trans. 2011, 40, 6104
44. World Health Organization. Cancer; Fact sheet No. 297; WHO Press: Geneva, 2013.
45. Lippert, B., Ed. Cisplatin-Chemistry and Biochemistry of a Leading Anticancer Drug, 1 st ed.; Wiley-VCH: Weinheim, Germany, 1999.
46. Peyrone, M. Ann. Chem. Pharm. 1844, 51, 1
47. Rosenberg, B. Interdiscip. Sci. Rev. 1978, 3, 134
48. Rosenberg, B. Platinum Met. Rev. 1971, 15, 42
49. Rosenberg, B. Naturwissenschaften 1973, 60, 399
50. Rosenberg, B.; VanCamp, L.; Krigas, T. Anti-Animal Tumor Method. U.S. Patent Office 4,177,263, 1979.
51. Eisenstein, R. I.; Resnick, D. S. Nat. Biotechnol. 2001, 19, 881
52. Blumenstyk, G. The Chronicles of Higher Education 1999, February 12, A39
53. Rosenberg, B.; VanCamp, L.; Krigas, T. Anti-Tumor Method. U.S. Patent Office 5,562,925, 1996.
54. Research Corp. Technologies, Inc. Patent Litigation, No. 97-2836 (D.N.J. Oct. 21, 1999), affirmed Research Corp. Techs., Inc. et al. v. Gensia Labs., Inc. et al., 10 Fed. Appx. 856 (Fed. Cir. 2001).
55. Reedijk, J. Chem. Rev. 1999, 99, 2499
56. Wang, D.; Lippard, S. J. Nat. Rev. Drug Discovery 2005, 4, 307
57. Berners-Price, S. J.; Appleton, T. G. In Platinum-Based Drugs in Cancer Therapy; Kelland, L.; Farrell, N. P., Eds.; Humana Press Inc.: Totowa, NJ, 2000; pp 3-35.
58. Berners-Price, S. J.; Ronconi, L.; Sadler, P. J. Prog. Nucl. Magn. Reson. Spectrosc. 2006, 49, 65
59. Cleare, M. J.; Hoeschele, J. D. Bioinorg. Chem. 1973, 2, 187
60. Cleare, M. J.; Hoeschele, J. D. Platinum Met. Rev. 1973, 17, 2
61. Cleare, M. J.; Hoeschele, J. D.; Rosenberg, B.; VanCamp, L. Malonato platinum anti-tumor compounds. U.S. Patent Office 4,140,707, 1979.
62. Kidani, Y.; Noji, M.; Tashiro, T. Gann 1980, 71, 637
63. Kidani, Y.; Masahide, N. Cytostatic platinum organic complexes. U.S. Patent Office 4,710,577, 1987.
64. Charest, G.; Sanche, L.; Fortin, D.; Mathieu, D.; Paquette, B. J. Neurooncol. 2013, 115, 365
65. Stathopoulos, P. G.; Rigatos, S.; Stathopoulos, J.; Batzios, S. J. Drug Delivery Ther. 2012, 2, 106
66. Boulikas, T. Expert Opin. Invest. Drugs 2009, 18, 1197
67. Regulon Inc.: Athens; http://www.lipoplatin.com (last accessed October 04, 2013).
68. Carr, J. L.; Tingle, M. D.; McKeage, M. J. Cancer Chemother. Pharmacol. 2006, 57, 483
69. Hall, M. D.; Hambley, T. W. Coord. Chem. Rev. 2002, 232, 49
70. Farrell, N.; Spinelli, S. In Uses of Inorganic Chemistry in Medicine; Farrell, N. P., Ed.; Royal Society of Chemistry: Cambridge, UK, 1999, Chapter 8; pp 124-134.
71. Hensing, T. A.; Hanna, N. H.; Gillenwater, H. H.; Camboni, M. G.; Allievi, C.; Socinski, M. A. Anti-Cancer Drugs 2006, 17, 697
72. Quiroga, A. G. Curr. Top. Med. Chem. 2011, 11, 2613
73. Kartalou, M.; Essigmann, J. M. Mutat. Res. 2001, 478, 23
74. Stewart, D. J. Crit. Rev. Oncol. Hematol. 2007, 63, 12
75. Kaiser, J. Science 2011, 331, 1542
76. Collery, P.; Domingo, J. L.; Keppler, B. K. Anticancer Res. 1996, 16, 687
77. Nordenberg, J.; Novogrodsky, A.; Beery, E.; Patia, M.; Wasserman, L.; Warshawsky, A. Eur. J. Cancer 1990, 26, 905
78. Niiki Pharma, Tampa (FL); http://www.niikipharma.com (last accessed July 22, 2013).
79. Bergamo, A.; Sava, G. Dalton Trans. 2007, 1267
80. Guidi, F.; Modesti, A.; Landini, I.; Nobili, S.; Mini, E.; Bini, L.; Puglia, M.; Casini, A.; Dyson, P. J.; Gabbiani, C.; Messori, L. J. Inorg. Biochem. 2013, 118, 94
81. Sava, G.; Bergamo, A.; Dyson, P. J. Dalton Trans. 2011, 40, 9069
82. Dwyer, F. P.; Gyarfas, E. C.; Roger, W. P.; Koch, J. H. Nature 1952, 170, 190
83. Hartinger, C. G.; Jakupec, M. A.; Zorbas-Seifried, S.; Groessl, M.; Egger, A.; Berger, W.; Zorbas, H.; Dyson, P. J.; Keppler, B. K. Chem. Biodiversity 2008, 5, 2140
84. Hartinger, C. G.; Zorbas-Seifried, S.; Jakupec, M. A.; Kynast, B.; Zorbas, H.; Keppler, B. K. J. Inorg. Biochem. 2006, 100, 891
85. Chen, S. J.; Zhou, G. B.; Zhang, X. W.; Mao, J. H.; de Thé, H.; Chen, Z. Blood 2011, 117, 6425
86. Lo-Coco, F. ATRA and arsenic trioxide (ATO) versus ATRA and idarubicin (AIDA) for newly diagnosed, non high-risk acute promyelocytic leukemia (APL): Results of the Phase III, prospective, randomoized, intergroup APL0406 study by the Italian-German cooperative groups Gimema-SAL-AMLSG. Paper No. 6; 54th Annual Meeting and Exposition of the American Society of Hematology: Atlanta, GA, December 2012.
87. Garnier, N.; Petruccelli, L. A.; Molina, M. F.; Kourelis, M.; Kwan, S.; Diaz, Z.; Schipper, H. M.; Gupta, A.; del Rincon, S. V.; Mann, K. K.; Miller, W. H. Leukemia 2013, 27, 2220
88. Finlay, I. G.; Mason, M. D.; Shelley, M. Lancet Oncol. 2005, 6, 392
89. Ramogida, C. F.; Orvig, C. Chem. Commun. 2013, 49, 4720
90. Volkert, W. A.; Goeckeler, W. F.; Ehrhardt, G. J.; Ketring, A. R. J. Nucl. Med. 1991, 32, 174
91. Smith, N. A.; Sadler, P. J. Philos. Trans. R. Soc., A 2013, 371, 20120519
92. Moore, C. M.; Emberton, M.; Bown, S. G. Lasers Surg. Med. 2011, 43, 768
93. Pinnacle Biologics, Bannockburn, IL; http://www.photofrin.com (last accessed October 11, 2013).
94. Stebabiotech SA, Luxembourg; http://www.stebabiotech.com (last accessed October 11, 2013).
95. Gibaud, S.; Jaouen, G. In Medicinal Organometallic Chemistry; Jaouen, G.; Metzler-Nolte, N., Eds.; Springer Verlag, Heidelberg, Germany, 2010; Chapter 1, pp 1-20.
96. Patra, M.; Gasser, G.; Metzler-Nolte, N. Dalton Trans. 2012, 41, 6350
97. Breinl, A.; Todd, J. L. Br. Med. J. 1907, 1, 132
98. Jolliffe, D. M. JRSM 1993, 86, 287
99. World Health Organization. Trypanosomiasis, Human African (Sleeping Sickness); Fact sheet No. 259; WHO Press: Geneva, 2013.
100. Goodwin, L. G. Trans. R. Soc. Trop. Med. Hyg. 1995, 89, 339
101. World Health Organization. Control of Leishmaniasis; Technical report no. 949; WHO Press: Geneva, 2010.
102. Olliaro, P. L.; Guerin, P. J.; Gerstl, S.; Haaskjold, A. A.; Rottingen, J.-A.; Sundar, S. Lancet Infect. Dis. 2005, 5, 763
103. Sun, H., Ed. Biological Chemistry of Arsenic, Antimony and Bismuth; Wiley: Weinheim, Germany, 2010.
104. Janssen, M. J. R.; Hendrikse, L.; de Boer, S. Y.; Bosboom, R.; De Boer, W. A.; Laheij, R. J. F.; Jansen, J. B. M. J. Neth. J. Med. 2006, 64, 191
105. Malfertheiner, P.; Bazzoli, F.; Delchier, J.-C.; Celiñski, K.; Giguère, M.; Rivière, M.; Mégraud, F.; the Pylera Study Group Lancet 2011, 377, 905
106. De Boer, W. A.; Van Etten, R. J.; Van De Wouw, B. A.; Schneeberger, P. M.; Van Oijen, A. H.; Jansen, J. B. Aliment. Pharmacol. Ther. 2000, 14, 85
107. Microbion Corp., Bozeman (MT); http://www.microbioncorp.com (last accessed July 22, 2013).
108. Eckhardt, S.; Brunetto, P. S.; Gagnon, J.; Priebe, M.; Giese, B.; Fromm, K. M. Chem. Rev. 2013, 113, 4708
109. Aziz, Z.; Abu, S. F.; Chong, N. J. Burns 2012, 38, 307
110. Wasiak, J.; Cleland, H.; Campbell, F.; Spinks, A. Dressings for superficial and partial thickness burns. Cochrane Database of Systematic Rev. 2013, Issue 3, Article No.: CD002106.
111. Garner, J. P.; Heppell, P. S. J. Burns 2005, 31, 539
112. Garner, J. P.; Heppell, P. S. J. Burns 2005, 31, 379
113. Clinical Trials USA 2013; http://www.clinicaltrials.gov.
114. Domarle, O.; Blampain, G.; Agnaniet, H.; Nzadiyabi, T.; Lebibi, J.; Brocard, J.; Maciejewski, L.; Biot, C.; Georges, A. J.; Millet, P. Antimicrob. Agents Chemother. 1998, 42, 540
115. Biot, C.; Nosten, F.; Fraisse, L.; Ter-Minassian, D.; Khalife, J.; Dive, D. Parasite 2011, 18, 207
116. Viamet, Durham (NC); http://www.viamet.com (last accessed July 22, 2013).
117. Majithia, V.; Geraci, S. A. Am. J. Med. 2007, 120, 936
118. Forestier, J. Lancet 1934, 224, 646
119. Berners-Price, S. J. In Bioinorganic Medicinal Chemistry; Alessio, E., Ed.; Wiley-VCH: Weinheim, Germany, 2011; Chapter 7, pp 197-222.
120. Benedek, T. G. J. Hist. Med. Allied Sci. 2004, 59, 50
121. Gunatilleke, S. S.; Barrios, A. M. J. Inorg. Biochem. 2008, 102, 555
122. The Research Committee of the Empire Rheumatism Council. Ann. Rheum. Dis. 1960, 19, 95.
123. Messori, L.; Marcon, G. In Metal Ions in Biological Systems Vol 41: Metal Ions and Their Complexes in Medication; Sigel, A.; Sigel, H., Eds.; Marcel Dekker Inc.: New York, 2004; Chapter 9, pp 279-304.
124. Pope, J. E.; Paul, H.; Koehler, B. E. J. Rheumatol. 2002, 29, 255
125. Lehman, A. J.; Esdaile, J. M.; Klinkhoff, A. V.; Grant, E.; Fitzgerald, A.; Canvin, J.; The METGO Study Group Arthritis & Rheumatism 2005, 52, 1360
126. Walz, D. T.; Dimartino, M. J.; Griswold, D. E.; Intoccia, A. P.; Flanagan, T. L. Am. J. Med. 1983, 75, 90
127. Thakor, A. S.; Jokerst, J.; Zavaleta, C.; Massoud, T. F.; Gambhir, S. S. Nano Lett. 2011, 11, 4029
128. Nejrup, K.; de Fine Olivarius, N.; Jacobsen, J. L.; Siersma, V. Clin. Rheumatol. 2008, 27, 1363
129. Lee, S.-M.; Kim, H. J.; Ha, Y.-J.; Park, Y. N.; Lee, S.-K.; Park, Y.-B.; Yoo, K.-H. ACS Nano 2013, 7, 50
130. Von Reis, G.; Swensson, A. Acta Med. Scand. (Suppl.) 1951, 259, 27
131. Berglöf, F. E. Acta Rheumatol. Scand. 1959, 5, 70
132. Bessant, R.; Steuer, A.; Rigby, S.; Gumpel, M. Rheumatology 2003, 42, 1036
133. Sheppeard, H.; Ward, D. J. Rheumatol. Rehabil. 1980, 19, 25
134. Goldstein, S.; Czapski, G.; Heller, A. Free Radical Biol. Med. 2005, 38, 839
135. World Health Organization. Diabetes; Fact sheet No. 312; WHO Press: Geneva, 2013.
136. Willsky, G. R.; Goldfine, A. B.; Kostyniak, P. J.; McNeill, J. H.; Yang, L. Q.; Khan, H. R.; Crans, D. C. J. Inorg. Biochem. 2001, 85, 33
137. Lyonnet, B. M.; Martz Martin, E. Presse Med. 1899, 7, 191
138. Josephson, L.; Cantley, L. C. Biochemistry 1977, 16, 4572
139. Heyliger, C. E.; Tahiliani, A. G.; McNeill, J. H. Science 1985, 227, 1474
140. Rehder, D. Coord. Chem. Rev. 1999, 182, 297
141. Cam, M. C.; Cros, G. H.; Serrano, J. J.; Lazaro, R.; McNeill, J. H. Diabetes Res. Clin. Pract. 1993, 20, 111
142. Thompson, K. H.; Orvig, C. Coord. Chem. Rev. 2001, 219, 1033
143. McNeill, J. H.; Yuen, V. G.; Hoveyda, H. R.; Orvig, C. J. Med. Chem. 1992, 35, 1489
144. Melchior, M.; Rettig, S. J.; Liboiron, B. D.; Thompson, K. H.; Yuen, V. G.; McNeill, J. H.; Orvig, C. Inorg. Chem. 2001, 40, 4686
145. Thompson, K. H.; Lichter, J.; LeBel, C.; Scaife, M. C.; McNeill, J. H.; Orvig, C. J. Inorg. Biochem. 2009, 103, 554
146. Thompson, K. H.; Orvig, C. Dalton Trans. 2006, 761
147. Thompson, K. H.; Orvig, C. J. Inorg. Biochem. 2006, 100, 1925
148. CFM-Pharma, B. V. Rotterdam; http://www.cfmpharma.com (last accessed July 22, 2013).
149. Wei, Y.-B.; Yang, X.-D. BioMetals 2012, 25, 1261
150. Medesis Pharmaceuticals Inc., Montreal; http://www.medesispharma.com (last accessed July 22, 2013).
151. Muñoz, M. C.; Barberà, A.; Domínguez, J.; Fernàndez-Alvarez, J.; Gomis, R.; Guinovart, J. J. Diabetes 2001, 50, 131
152. Claret, M.; Corominola, H.; Canals, I.; Saura, J.; Barcelo-Batllori, S.; Guinovart, J. J.; Gomis, R. Endocrinology 2005, 146, 4362
153. Barbera, A.; Gomis, R. R.; Prats, N.; Rodriguez-Gil, J. E.; Domingo, M.; Gomis, R.; Guinovart, J. J. Diabetologia 2001, 44, 507
154. Hanzu, F.; Gomis, R.; Coves, M. J.; Viaplana, J.; Palomo, M.; Andreu, A.; Szpunar, J.; Vidal, J. Diabetes, Obes. Metab. 2010, 12, 1013
155. REDOX Pharmaceutical Corp., Greenvale, NY; http://www.redoxpharm.com (last accessed July 22, 2013).
156. Schwartz, J. A.; Lium, E. K.; Silverstein, S. J. J. Virol. 2001, 75, 4117
157. Louie, A. Y.; Meade, T. J. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 6663
158. Rozenbaum, W.; Dormont, D.; Spire, B.; Vilmer, E.; Gentilini, M.; Griscelli, C.; Montagnier, L.; Barre-Sinoussi, F.; Chermann, J. C. Lancet 1985, 325, 450
159. Stephan, H.; Kubeil, M.; Emmerling, F.; Müller, C. E. Eur. J. Inorg. Chem. 2013, 2013, 1585
160. Dan, K.; Miyashita, K.; Seto, Y.; Fujita, H.; Yamase, T. Pharmacol. Res. 2002, 46, 357
161. Zhang, H.; Qi, Y.; Ding, Y.; Wang, J.; Li, Q.; Zhang, J.; Jiang, Y.; Chi, X.; Li, J.; Niu, J. Bioorg. Med. Chem. Lett. 2012, 22, 1664
162. Yamase, T. J. Mater. Chem. 2005, 15, 4773
163. De Clercq, E. Nat. Rev. Drug Discovery 2003, 2, 581
164. Eickhoff, T. C. Vaccine 2002, 20, S1
165. "Minamata" Convention Agreed by Nations-Global Mercury Agreement to Lift Health Threats from Lives of Millions World-Wide; http://www.unep.org/newscentre.default.aspx?DocumentID2702&ArticleID9373 (last accessed July 22, 2013) and http://www.mercuryconvention.org (last accessed November 08, 2013).
166. The Micronutrient Initiative, Ottawa; http://www.micronutrient.org (last accessed July 22, 2013).
167. Andersen, O. Mini-Rev. Med. Chem. 2004, 4, 11
168. Harrison, O. Vitamin & Supplement Manufacturing in the U.S.; U.S. Industry Report No. 32541d; IBIS World: U.S., 2013.
169. NCT 00001262, Clinical Trials USA 2013; http://www.clinicaltrials.gov (last accessed July 22, 2013).
170. Ganite; FDA-approved label, 2003.
171. Bouillon, R.; Burckhardt, P.; Christiansen, C.; Fleisch, H. A.; Fujita, T.; Gennari, C.; Martin, T. J.; Mazzuoli, G.; Melton, L. J.; Ringe, J. D.; Riis, P.; Peck, W. A.; Samsioe, G.; Shulman, L. E. Am. J. Med. 1991, 90, 107
172. Jonville-Bera, A.-P.; Autret-Leca, E. Presse Med. 2011, 40, 453
173. European Medicines Agency. European Medicines Agency confirms positive benefit-risk balance of Protelos/Osseor, but recommends new contraindications and revised warnings; Press release March 16, 2012; http://www.ema.europa.eu.
174. European Medicines Agency. Recommendation to restrict the use of Protelos/Osseor (Strontium ranelate); Press release April 26, 2013; http://www.ema.europa.eu.
175. Tinker, J. H.; Michenfelder, J. D. Anestesiology 1976, 45, 340
176. de C. Pereira, A.; Ford, P. C.; da Silva, R. S.; Bendhack, L. M. Nitric Oxide 2011, 24, 192
177. Wecksler, S. R.; Mikhailovsky, A.; Korystov, D.; Buller, F.; Kannan, R.; Tan, L.-S.; Ford, P. C. Inorg. Chem. 2007, 46, 395
178. Silva, J. J. N.; Osakabe, A. L.; Pavanelli, W. R.; Silva, J. S.; Franco, D. W. Br. J. Pharmacol. 2007, 152, 112
179. Cameron, B. R.; Darkes, M. C.; Baird, I. R.; Skerlj, R. T.; Santucci, Z. L.; Fricker, S. P. Inorg. Chem. 2003, 42, 4102
180. Valentine, J. Chem. Rev., in this edition.
181. Inagi, R. In Frontiers in Cardiovascular Drug Discovery; Rahman, A.-u.; Choudhary, M. I., Eds.; Bentham Science Publishers Ltd.: Sharjah, 2010; Vol. 1, pp 138-153.
182. Batinić-Haberle, I.; Rebouças, J. S.; Spasojević, I. Antioxid. Redox Signaling 2010, 13, 877
183. Cuzzocrea, S.; Mazzon, E.; Dugo, L.; Di Paola, R.; Caputi, A. P.; Salvemini, D. FASEB J. 2004, 18, 94
184. Friedel, F. C.; Lieb, D.; Ivanović-Burmazović, I. J. Inorg. Biochem. 2012, 109, 26
185. Wang, Z.-Q.; Porreca, F.; Cuzzocrea, S.; Galen, K.; Lightfood, R.; Masini, E.; Muscoli, C.; Mollace, V.; Ndengele, M.; Ischiropoulos, H.; Salvemini, D. J. Pharmacol. Exp. Ther. 2004, 309, 869
186. Birch, N. J. Chem. Rev. 1999, 99, 2659
187. Price, L. H.; Heninger, G. R. N. Engl. J. Med. 1994, 331, 591
188. McCarthy, M. J.; Leckband, S. G.; Kelsoe, J. R. Pharmacogenomics 2010, 11, 1439
189. Duffy, A.; Alda, M.; Kutcher, S.; Cavazzoni, P.; Robertson, C.; Grof, E.; Grof, P. J. Clin. Psychiatry 2002, 63, 1171
190. Grof, P.; Duffy, A.; Cavazzoni, P.; Grof, E.; Garnham, J.; MacDougall, M.; O'Donovan, C.; Alda, M. J. Clin. Psychiatry 2002, 63, 942
191. Malhi, G. S.; Tanious, M.; Das, P.; Coulston, C. M.; Berk, M. CNS Drugs 2013, 27, 135
192. Hajek, T.; Bauer, M.; Simhandl, C.; Rybakowski, J.; O'Donovan, C.; Pfenning, A.; König, B.; Suwalska, A.; Yucel, K.; Uher, R.; Young, L. T.; MacQueen, G.; Alda, M. Psychol. Med 2014, 44, 507
193. Pouladi, M. A.; Brillaud, E.; Xie, Y.; Conforti, P.; Graham, R. K.; Ehrnhoefer, D. E.; Franciosi, S.; Zhang, W.; Poucheret, P.; Compte, E.; Maurel, J.-C.; Zuccato, C.; Cattaneo, E.; Neri, C.; Hayden, M. R. Neurobiol. Dis. 2012, 48, 282
194. Blindauer, C. Biochem. Mag. 2012, 34, 4
195. Andersen, O. Chem. Rev. 1999, 99, 2683
196. Bickel, H.; Hall, G. E.; Keller-Schierlein, W.; Prelog, V.; Vischer, E.; Wettstein, A. Helv. Chim. Acta 1960, 43, 2129
197. Coburn, J. W. Nefrologia (Suppl. 3) 1993, 13, 123
198. Flora, S. J.; Flora, G.; Saxena, G.; Mishra, M. Cell Mol. Biol. 2007, 53, 26
199. Cappellini, M. D.; Cohen, A.; Piga, A.; Bejaoui, M.; Perrotta, S.; Agaoglu, L.; Aydinok, Y.; Kattamis, A.; Kilinc, Y.; Porter, J.; Capra, M.; Galanello, R.; Fattoum, S.; Drelichman, G.; Magnano, C.; Verissimo, M.; Athanassiou-Metaxa, M.; Giardina, P.; Kourakli-Symeonidis, A.; Janka-Schaub, G.; Coates, T.; Vermylen, C.; Olivieri, N.; Thuret, I.; Opitz, H.; Ressayre-Djaffer, C.; Marks, P.; Alberti, D. Blood 2006, 107, 3455
200. Giardini, C. Curr. Opin. Hematol. 1997, 4, 79
201. Cohen, A. R.; Galanello, R.; Piga, A.; De Sanctis, V.; Tricta, F. Blood 2003, 102, 1583
202. de Bie, P.; Muller, P.; Wijmenga, C.; Klomp, L. W. J. J. Med. Genet. 2007, 44, 673
203. Alvarez, H. M.; Xue, Y.; Robinson, C. D.; Canalizo-Hernández, M. A.; Marvin, R. G.; Kelly, R. A.; Mondragón, A.; Penner-Hahn, J. E.; O'Halloran, T. V. Science 2010, 327, 331
204. Brewer, G. J.; Hedera, P.; Kluin, K. J.; Carlson, M.; Askari, F.; Dick, R. B.; Sitterly, J.; Fink, J. K. Arch. Neurol. 2003, 60, 379
205. World Health Organization. Dementia; Fact sheet No. 362; WHO Press: Geneva, 2012.
206. Lesage, S.; Brice, A. Hum. Mol. Genet. 2009, 18, R48
207. Scott, L. E.; Orvig, C. Chem. Rev. 2009, 109, 4885
208. Telpoukhovskaia, M. A.; Orvig, C. Chem. Soc. Rev. 2013, 42, 1836
209. Badrick, A. C.; Jones, C. E. Curr. Top. Med. Chem. 2011, 11, 543
210. Sharpe, P. C.; Richardson, D. R.; Kalinowski, D. S.; Bernhardt, P. V. Curr. Top. Med. Chem. 2011, 11, 591
211. Bareggi, S. R.; Cornelli, U. CNS Neurosci. Ther. 2012, 18, 41
212. Ritchie, C. W.; Bush, A. I.; Mackinnon, A.; Macfarlane, S.; Mastwyk, M.; MacGregor, L.; Kiers, L.; Cherny, R.; Li, Q.-X.; Tammer, A.; Carrington, D.; Mavros, C.; Volitakis, I.; Xilinas, M.; Ames, D.; Davis, S.; Beyreuther, K.; Tanzi, R. E.; Masters, C. L. Arch. Neurol. 2003, 60, 1685
213. Lannfelt, L.; Blennow, K.; Zetterberg, H.; Batsman, S.; Ames, D.; Harrison, J.; Masters, C. L.; Targum, S.; Bush, A. I.; Murdoch, R.; Wilson, J.; Ritchie, C. W. Lancet Neurol. 2008, 7, 779
214. Prana Biotechnology Limited, Parkville (VIC); http://www.pranabio.com (last accessed July 22, 2013).
215. Relkin, N. R. Lancet Neurol. 2008, 7, 762
216. Moe, S.; Drüeke, T.; Cunningham, J.; Goodman, W.; Martin, K.; Olgaard, K.; Ott, S.; Sprague, S.; Lameire, N. Kidney Int. 2006, 69, 1945
217. Bover, J.; Andrés, E.; Lloret, M. J.; Aguilar, A.; Ballarín, J. Blood Purif. 2009, 27, 369
218. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am. J. Kidney Dis. (Supp. 3) 2003, 42, S1; http://www.kidney.org/professionals/kdoqi/guidelines-bone/index. htm (last accessed July 22, 2013).
219. Mehrotra, R.; Martin, K. J.; Fishbane, S.; Sprague, S. M.; Zeig, S.; Anger, M. Clin. J. Am. Soc. Nephrol. 2008, 3, 1437
220. Awah, N. W.; Kaneko, A. Clin. Infect. Dis. 2012, 54, 1145
221. Menendez, C.; Kahigwa, E.; Kahigwa, E.; Hirt, R.; Vounatsou, P.; Aponte, J. J.; Font, F.; Acosta, C. J.; Schellenberg, D. M.; Galindo, C. M.; Kimario, J.; Urassa, H.; Brabin, B.; Smith, T. A.; Kitua, A. Y.; Tanner, M.; Alonso, P. L. Lancet 1997, 350, 844
222. Smith, H. J.; Meremikwu, M. M. Iron-chelating agents for treating malaria. Cochrane Database of Systematic Rev. 2003, Issue 2, Article No.: CD001474.
223. Driggers, E. M.; Hale, S. P.; Lee, J.; Terret, N. K. Nat. Rev. Drug Discovery 2008, 7, 608
224. De Clercq, E. Pharmacol. Therap. 2010, 128, 509
225. Mann, B. S.; Johnson, J. R.; Cohen, M. H.; Justice, R.; Pazdur, R. The Oncologist 2007, 12, 1247
226. Sun, H.; Chai, Z.-F. Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem. 2010, 106, 20
227. Mounicou, S.; Szpunar, J.; Lobinski, R. Chem. Soc. Rev. 2009, 38, 1119
228. Szpunar, J. Analyst 2005, 130, 442
229. Harford, C.; Sarkar, B. Acc. Chem. Res. 1997, 30, 123
230. Sankararamakrishnan, R.; Verma, S.; Kumar, S. Proteins 2005, 58, 211
231. Parkin, G. Chem. Rev., in this edition.
232. Solomon, E. I. Chem. Rev., in this edition.
233. de Almeida, A.; Oliveira, B. L.; Correia, J. D. G.; Soveral, G.; Casini, A. Coord. Chem. Rev. 2013, 257, 2689
234. Barry, N. P. E.; Sadler, P. J. Chem. Commun. 2013, 49, 5106
235. Barry, N. P. E.; Sadler, P. J. ACS Nano 2013, 7, 5654
236. Sava, G.; Jaouen, G.; Hillard, E. A.; Bergamo, A. Dalton Trans. 2012, 41, 8226
237. Navarro, M.; Gabbiani, C.; Messori, L.; Gambino, D. Drug Discovery Today 2010, 15, 1070
238. Berthron, G., Ed. Handbook of Metal-Ligand Interactions in Biological Fluids; Marcel Dekker Inc.: New York, 1995; Vols. 1-2.
239. Groessl, M.; Dyson, P. J. Curr. Top. Med. Chem. 2011, 11, 2632
240. Parker, L. J.; Ascher, D. B.; Gao, C.; Miles, L. A.; Harris, H. H.; Parker, M. W. J. Inorg. Biochem. 2012, 115, 138
241. Petković, M.; Kamčeva, T. Metallomics 2011, 3, 550
242. Meermann, B.; Sperling, M. Anal. Bioanal. Chem. 2012, 403, 1501
243. Bytzek, A. K.; Hartinger, C. G. Electrophoresis 2012, 33, 622
244. Rodríguez-Rodríguez, C.; Telpoukhovskaia, M.; Orvig, C. Coord. Chem. Rev. 2012, 256, 2308
245. Wong, G. T. Alzheimer Research Forum; August 28, 2007; http://www.alzforum.org/new/detail.asp?id=1647 (last accessed July 22, 2013).
246. Meggers, E. Curr. Opin. Chem. Biol. 2007, 11, 287
247. Storr, T.; Thompson, K. H.; Orvig, C. Chem. Soc. Rev. 2006, 35, 534
248. Meggers, E. Chem. Commun. 2009, 1001
249. Huang, R.; Wallqvist, A.; Covell, D. G. Biochem. Pharmacol. 2005, 69, 1009
250. Siegbahn, P. Chem. Rev., in this edition.
251. Meggers, E.; Atilla-Gokcumen, G. E.; Gründler, K.; Frias, C.; Prokop, A. Dalton Trans. 2009, 10882
252. Bullock, A. N.; Russo, S.; Amos, A.; Pagano, N.; Bregman, H.; Debreczeni, J. é.; Lee, W. H.; von Delft, F.; Meggers, E.; Knapp, S. PLoS One 2009, 4, e7112
253. Süss-Fink, G. Dalton Trans. 2010, 39, 1673
254. Aird, R. E.; Cummings, J.; Ritchie, A. A.; Muir, M.; Morris, R. E.; Chen, H.; Sadler, P. J.; Jodrell, D. I. Br. J. Cancer 2002, 86, 1652
255. Bergamo, A.; Masi, A.; Peacock, A. F. A.; Habtemariam, A.; Sadler, P. J.; Sava, G. J. Inorg. Biochem. 2010, 104, 79
256. Scolaro, C.; Bergamo, A.; Brescacin, L.; Delfino, R.; Cocchietto, M.; Laurenczy, G.; Geldbach, T. J.; Sava, G.; Dyson, P. J. J. Med. Chem. 2005, 48, 4161
257. Ratanaphan, A.; Temboot, P.; Dyson, P. J. Chem. Biodiversity 2010, 7, 1290
258. Romero-Canelón, I.; Sadler, P. J. Inorg. Chem. 2013, 52, 12276
259. Casini, A.; Reedijk, J. Chem. Sci. 2012, 3, 3135
260. Harris, W. R.; Sheldon, J. Inorg. Chem. 1990, 29, 119
261. Campbell, R. F.; Chasteen, N. D. J. Biol. Chem. 1977, 252, 5996
262. Zak, O.; Aisen, P. Biochemistry 1988, 27, 1075
263. Albert, A. Selective Toxicity-The Physico-chemical Basis of Therapy, 7 th ed.; Chaoman and Hall: London, UK; New York, 1985.
264. Huttunen, K. M.; Rautio, J. Curr. Top. Med. Chem. 2011, 11, 2265
265. Sharma, V.; Piwnica-Worms, D. Chem. Rev. 1999, 99, 2545
266. Salas, P. F.; Herrmann, C.; Orvig, C. Chem. Rev. 2013, 113, 3450
267. Gasser, G.; Ott, I.; Metzler-Nolte, N. J. Med. Chem. 2011, 54, 3
268. Wyatt, P. G.; Gilbert, I. H.; Read, K. D.; Fairlamb, A. H. Curr. Top. Med. Chem. 2011, 11, 1275
269. Collins, I.; Workman, P. Nat. Chem. Biol. 2006, 2, 689
270. Gunaratna, C. Curr. Sep. Drug Dev. 2000, 19, 17
271. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Adv. Drug Delivery Rev. 2001, 46, 3
272. Fricker, S. P. Dalton Trans. 2007, 4903
273. Baes, C. J.; Mesmer, R. E. The Hydrolysis of Cations; Robert F. Krieger Publishing Company: Malabar, FL, 1986.
274. Harris, W. R.; Carrano, C. J.; Cooper, S. R.; Sofen, S. R.; Avdeef, A. E.; McArdle, J. V.; Raymond, K. N. J. Am. Chem. Soc. 1979, 101, 6097
275. Pritchard, J. F.; Jurima-Romet, M.; Reimer, M. L. J.; Mortimer, E.; Rolfe, B.; Cayen, M. N. Nat. Rev. Drug Discovery 2003, 2, 542
276. Sanchez-Cano, C.; Hannon, M. J. Dalton Trans. 2009, 10702
277. Johnstone, T. C.; Kulak, N.; Pridgen, E. M.; Farokhzad, O. C.; Langer, R.; Lippard, S. J. ACS Nano 2013, 7, 5675
278. Stathopoulos, G. P.; Antoniou, D.; Dimitroulis, J.; Stathopoulous, J.; Marosis, K.; Michalopoulou, P. Cancer Chemother. Pharmacol. 2011, 68, 945
279. Stathopoulous, G. P.; Boulikas, T.; Kourvetaris, A.; Stathopoulous, J. Anticancer Res. 2006, 26, 1489
280. Arrowsmith, J.; Miller, P. Nat. Rev. Drug Discovery 2013, 12, 569
281. Vincent, J. In The Bioinorganic Chemistry of Chromium; Vincent, J., Ed.; John Wiley & Sons Ltd.: Chichester, UK, 2013; Chapter 2, pp 7-30.
282. Functional metal complexes that bind to biomolecules. Action CM1105 (2012-2016); http://www.cm1105.eu (last accessed July 22, 2013).
283. Theophrast von Hohenheim, P. In Sieben Defensiones (Antwort auf etliche Verunglimpfungen seiner Misgönner); Sudhoff, K., Ed.; Klassiker der Medizin; Verlag von Johann Ambrosius Barth: Leipzig, Germany, 1915.
284. Bertrand, G. 8th Int. Congr. Appl. Chem. 1912, 28, 30